Set designer Derek McLane speaks at Harvard October 14

Award-winning theatrical set designer Derek McLane ’80 will speak about his work at Harvard on October 14.

Derek McLane

Theatrical set designer Derek McLane ’80, subject of a 2008 profile in Harvard Magazine, comes to the Harvard campus on Thursday, October 14, where he will give a slide lecture and answer questions on his career and creative process at the New College Theatre, starting at 7:00 p.m. The event, staged by the Learning from Performers program and the Harvard Office of Career Services, is free and open to the public. McLane has received two OBIE Awards and a 2009 Tony Award for best scenic design of a play. His credits include the recent Broadway revival of Ragtime. 

You might also like

A (Truly) Naked Take on Second-Wave Feminism

Playwright Bess Wohl’s Liberation opens on Broadway.

‘Passengers’ at A.R.T. Blends Acrobatics with Einstein’s Relativity

Review: Quantum mechanics meets circus arts at the American Repertory Theater’s performance

Bringing Korean Stories to Life

Composer Julia Riew writes the musicals she needed to see.

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

Harvard’s Class of 2029 Reflects Shifts in Racial Makeup After Affirmative Action Ends

International students continue to enroll amid political uncertainty; mandatory SATs lead to a drop in applications.

Harvard Football: Harvard 35, Princeton 14

Still undefeated after subduing the Tigers, the Crimson await Dartmouth.

Explore More From Current Issue

A person walks across a street lined with historic buildings and a clock tower in the background.

Harvard In the News

A legal victory against Trump, hazing in the Harvard-Radcliffe Orchestra, and kicking off a Crimson football season with style

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.